R3 Stem Cell offers a disease awareness library of conditions, which you can learn a lot about by clicking below. Currently, R3 Stem Cell has received Institutional Review Board (IRB) for the investigation of certain condition categories. You can read about the study on ClinicalTrials.gov here:
SAFETY AND CLINICAL OUTCOMES WITH AMNIOTIC AND UMBILICAL CORD TISSUE THERAPY
welcome to r3 international
Call to Schedule Consultation at Over
35 Centers Nationwide!